Today Citeab has added antibodies from Finnish biotechnology company Hytest. The company focuses especially on development of antibodies suitable for cardiovascular disease diagnostics and has 4T21 – 19C7 in their range, which is the most used high affinity monoclonal antibody for human troponin I.

Pekka Hilden explains that Hytest abs stand out because they are developed using a scientific approach that takes into account  the disease state as well as the target molecule behavior.

A full list of HyTest antibodies is available at http://www.citeab.co.uk/search?c=56